creatine has been researched along with Lupus Erythematosus, Systemic in 25 studies
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In women with SLE with mild-moderate disease activity, ferritin, oestradiol and uric acid levels at mid-gestation may predict preterm birth." | 3.79 | Predictors of preterm birth in patients with mild systemic lupus erythematosus. ( Clowse, ME; Criscione-Schreiber, LG; James, A; Pisetsky, DS; Wallace, DJ; Weisman, M, 2013) |
| "The N-acetylaspartate-to-creatine/phosphocreatine ratio was smaller in those patients with significant cerebral atrophy (1." | 3.69 | Analysis of cerebral structural changes in systemic lupus erythematosus by proton MR spectroscopy. ( Griffey, RH; Hart, BL; Haseler, LJ; Matwiyoff, NA; Sibbitt, RR; Sibbitt, WL, 1994) |
| "We evaluated retrospectively the effect of superimposed pregnancy upon the course of systemic lupus erythematosus (SLE) in patients receiving glucocorticoids or azathioprine at conception." | 3.67 | Pregnancy among patients with systemic lupus erythematosus receiving immunosuppressive therapy. ( Dorsey, JK; Meehan, RT, 1987) |
| " Additionally, self-reported adverse events were recorded throughout the trial." | 2.79 | Efficacy and safety of creatine supplementation in childhood-onset systemic lupus erythematosus: a randomized, double-blind, placebo-controlled, crossover trial. ( de Sá Pinto, AL; Gualano, B; Hayashi, AP; Otaduy, MC; Pereira, RM; Sallum, AM; Sapienza, MT; Silva, CA; Solis, MY, 2014) |
| "The patient had persistent joint pain and weakness after intravenous methylprednisolone administration and complained of an inability to walk with a positive test for Gower's sign one week after admission, accompanied by elevated alanine aminotransferase (ALT) and creatine-phospho-kinase (CPK) levels." | 1.72 | Overlap syndrome in a 12-year-old girl with systemic lupus erythematosus and anti-oj antibody-positive polymyositis: a case report. ( Kao, JK; Lin, KH, 2022) |
| "Insulin sensitivity was estimated using the homeostatic model assessment index (HOMA-B) for beta cell function and (HOMA-IR) for peripheral tissue insulin resistance." | 1.39 | Metabolic syndrome and insulin resistance comorbidity in systemic lupus erythematosus. Effect on carotid intima-media thickness. ( Abdel-Rasheed, E; El-Fishawy, H; Gheita, TA; Nasrallah, MM; Raafat, HA; Sayed, S, 2013) |
| "Moreover, depression was significantly correlated with titers of autoantibodies against DNA, NMDA receptors and cardiolipin." | 1.35 | Depression is an early disease manifestation in lupus-prone MRL/lpr mice. ( Campbell, SR; Cui, MH; Gao, HX; Gulinello, M; Hee-Hwang, J; Putterman, C; Zong, P, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (28.00) | 18.7374 |
| 1990's | 5 (20.00) | 18.2507 |
| 2000's | 7 (28.00) | 29.6817 |
| 2010's | 4 (16.00) | 24.3611 |
| 2020's | 2 (8.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, KH | 1 |
| Kao, JK | 1 |
| Kilic, H | 3 |
| Sahin, S | 3 |
| Toprak, MF | 3 |
| Hatay, GH | 3 |
| Yilmaz, K | 3 |
| Adrovic, A | 3 |
| Barut, K | 3 |
| Ozturk Isik, E | 3 |
| Tuzun, E | 3 |
| Kizilkilic, O | 3 |
| Saltik, S | 3 |
| Kasapcopur, O | 3 |
| Hayashi, AP | 1 |
| Solis, MY | 1 |
| Sapienza, MT | 1 |
| Otaduy, MC | 1 |
| de Sá Pinto, AL | 1 |
| Silva, CA | 1 |
| Sallum, AM | 1 |
| Pereira, RM | 1 |
| Gualano, B | 1 |
| Gao, HX | 1 |
| Campbell, SR | 1 |
| Cui, MH | 1 |
| Zong, P | 1 |
| Hee-Hwang, J | 1 |
| Gulinello, M | 1 |
| Putterman, C | 1 |
| Filley, CM | 2 |
| Kozora, E | 2 |
| Brown, MS | 2 |
| Miller, DE | 2 |
| West, SG | 2 |
| Arciniegas, DB | 2 |
| Grimm, A | 1 |
| Zhang, L | 2 |
| Pelzman, J | 1 |
| Gheita, TA | 1 |
| Raafat, HA | 1 |
| Sayed, S | 1 |
| El-Fishawy, H | 1 |
| Nasrallah, MM | 1 |
| Abdel-Rasheed, E | 1 |
| Clowse, ME | 1 |
| Wallace, DJ | 1 |
| Weisman, M | 1 |
| James, A | 1 |
| Criscione-Schreiber, LG | 1 |
| Pisetsky, DS | 1 |
| MACHTEY, I | 1 |
| POLLAK, VE | 1 |
| PIRANI, CL | 1 |
| SCHWARTZ, FD | 1 |
| Handa, R | 1 |
| Sahota, P | 1 |
| Kumar, M | 1 |
| Jagannathan, NR | 1 |
| Bal, CS | 1 |
| Gulati, M | 1 |
| Tripathi, BM | 1 |
| Wali, JP | 1 |
| Appenzeller, S | 1 |
| Li, LM | 1 |
| Costallat, LT | 1 |
| Cendes, F | 1 |
| Sibbitt, WL | 4 |
| Haseler, LJ | 2 |
| Griffey, RH | 1 |
| Hart, BL | 1 |
| Sibbitt, RR | 1 |
| Matwiyoff, NA | 1 |
| Griffey, RR | 1 |
| Friedman, SD | 1 |
| Brooks, WM | 3 |
| Sabet, A | 1 |
| Barker, PB | 1 |
| van Zijl, PC | 1 |
| Duyn, JH | 1 |
| Moonen, CT | 1 |
| Jung, RE | 1 |
| Ford, CC | 1 |
| Greinel, EJ | 1 |
| Kaplanski, G | 1 |
| Cacoub, P | 1 |
| Farnarier, C | 1 |
| Marin, V | 1 |
| Grégoire, R | 1 |
| Gatel, A | 1 |
| Durand, JM | 1 |
| Harlé, JR | 1 |
| Bongrand, P | 1 |
| Piette, JC | 1 |
| Al-Maini, MH | 1 |
| Mountz, JD | 1 |
| Al-Mohri, HA | 1 |
| El-Ageb, EM | 1 |
| Al-Riyami, BM | 1 |
| Svenson, KL | 1 |
| Zhou, T | 1 |
| Richens, ER | 1 |
| Axford, JS | 1 |
| Howe, FA | 1 |
| Heron, C | 1 |
| Griffiths, JR | 1 |
| Hackshaw, KV | 1 |
| Voelkel, NF | 1 |
| Thomas, RB | 1 |
| Westcott, JY | 1 |
| Meehan, RT | 1 |
| Dorsey, JK | 1 |
| Garcia-Caceres, U | 1 |
| Ortega, J | 1 |
| Muth, RG | 1 |
| Kreysel, H | 1 |
| Jänner, M | 1 |
| Wehrmann, R | 1 |
| Kobayashi, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Creatine Supplementation in Patients With Juvenile Systemic Lupus Erythematosus and Juvenile Dermatomyositis[NCT01217320] | 40 participants (Anticipated) | Interventional | 2011-01-31 | Recruiting | |||
| Libman-Sacks Endocarditis as a Cause of Neuropsychiatric Systemic Lupus Erythematosus[NCT00858884] | 68 participants (Actual) | Interventional | 2006-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for creatine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Efficacy and safety of creatine supplementation in childhood-onset systemic lupus erythematosus: a randomized, double-blind, placebo-controlled, crossover trial.
Topics: Adolescent; Anaerobic Threshold; Body Composition; Bone Remodeling; Child; Creatine; Cross-Over Stud | 2014 |
24 other studies available for creatine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Overlap syndrome in a 12-year-old girl with systemic lupus erythematosus and anti-oj antibody-positive polymyositis: a case report.
Topics: Adult; Alanine Transaminase; Antibodies, Antinuclear; Arthralgia; Autoantibodies; Child; Creatine; C | 2022 |
Assessment of myelin oligodendrocyte glycoprotein antibodies and magnetic resonance spectroscopy in childhood-onset systemic lupus erythematosus.
Topics: Choline; Creatine; Humans; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; | 2023 |
Assessment of myelin oligodendrocyte glycoprotein antibodies and magnetic resonance spectroscopy in childhood-onset systemic lupus erythematosus.
Topics: Choline; Creatine; Humans; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; | 2023 |
Assessment of myelin oligodendrocyte glycoprotein antibodies and magnetic resonance spectroscopy in childhood-onset systemic lupus erythematosus.
Topics: Choline; Creatine; Humans; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; | 2023 |
Assessment of myelin oligodendrocyte glycoprotein antibodies and magnetic resonance spectroscopy in childhood-onset systemic lupus erythematosus.
Topics: Choline; Creatine; Humans; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; | 2023 |
Depression is an early disease manifestation in lupus-prone MRL/lpr mice.
Topics: Animals; Aspartic Acid; Autoantibodies; Brain; Cardiolipins; Choline; Chromatin; Creatine; Depressio | 2009 |
White matter microstructure and cognition in non-neuropsychiatric systemic lupus erythematosus.
Topics: Adult; Aspartic Acid; Axons; Brain; Brain Chemistry; Choline; Cognition; Cognition Disorders; Creati | 2009 |
Memory impairment associated with neurometabolic abnormalities of the hippocampus in patients with non-neuropsychiatric systemic lupus erythematosus.
Topics: Adult; Aspartic Acid; Case-Control Studies; Creatine; Female; Glutamic Acid; Hippocampus; Humans; Lu | 2011 |
Metabolic syndrome and insulin resistance comorbidity in systemic lupus erythematosus. Effect on carotid intima-media thickness.
Topics: Adult; Blood Glucose; Carotid Intima-Media Thickness; Comorbidity; Creatine; Female; Humans; Insulin | 2013 |
Predictors of preterm birth in patients with mild systemic lupus erythematosus.
Topics: Adult; Biomarkers; Cohort Studies; Comorbidity; Creatine; Estradiol; Female; Ferritins; Gestational | 2013 |
[DERMATOMYOSITIS].
Topics: Creatine; Creatinine; Dermatomyositis; Diagnosis, Differential; Electromyography; Humans; Lupus Eryt | 1964 |
THE NATURAL HISTORY OF THE RENAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS.
Topics: Arteries; Black People; Blood Chemical Analysis; Creatine; Creatinine; Glomerulonephritis; Kidney Di | 1964 |
In vivo proton magnetic resonance spectroscopy (MRS) and single photon emission computerized tomography (SPECT) in systemic lupus erythematosus (SLE).
Topics: Adult; Aspartic Acid; Brain; Cerebrovascular Circulation; Creatine; Female; Humans; Lupus Erythemato | 2003 |
Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
Topics: Adult; Analysis of Variance; Antibodies, Antiphospholipid; Aspartic Acid; Axons; Biomarkers; Brain; | 2005 |
Analysis of cerebral structural changes in systemic lupus erythematosus by proton MR spectroscopy.
Topics: Adolescent; Adult; Aspartic Acid; Atrophy; Brain; Choline; Creatine; Energy Metabolism; Female; Huma | 1994 |
Neurometabolism of active neuropsychiatric lupus determined with proton MR spectroscopy.
Topics: Adult; Aspartic Acid; Brain; Brain Damage, Chronic; Brain Ischemia; Brain Mapping; Choline; Creatine | 1997 |
Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus.
Topics: Adult; Aspartic Acid; Biomarkers; Cerebral Ventricles; Choline; Creatine; Female; Humans; Lactic Aci | 1997 |
Relationship between neurometabolite derangement and neurocognitive dysfunction in systemic lupus erythematosus.
Topics: Adult; Aspartic Acid; Brain; Choline; Cognition Disorders; Creatine; Female; Humans; Lupus Erythemat | 1999 |
Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with the severity of thrombosis.
Topics: Adult; Aged; Brain Diseases; Creatine; E-Selectin; Female; Humans; Intercellular Adhesion Molecule-1 | 2000 |
Serum levels of soluble Fas correlate with indices of organ damage in systemic lupus erythematosus.
Topics: Adolescent; Adult; Alanine Transaminase; Apoptosis; Arabs; Aspartate Aminotransferases; Biomarkers; | 2000 |
Sensitivity of quantitative (1)H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus.
Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain Diseases; Case-Control Studies; Choline; Creatine; Fem | 2001 |
Urine leukotriene E4 levels are elevated in patients with active systemic lupus erythematosus.
Topics: Adult; Arthritis, Rheumatoid; Creatine; Female; Humans; Leukotriene E4; Lupus Erythematosus, Systemi | 1992 |
Pregnancy among patients with systemic lupus erythematosus receiving immunosuppressive therapy.
Topics: Azathioprine; Creatine; Female; Fertilization; Humans; Immunosuppression Therapy; Lupus Erythematosu | 1987 |
Studies of tubular alterations in diffuse renal disease. II. Quantitative evaluation of cellularity and length of proximal convoluted tubules in the kidney of lupus nephritis.
Topics: Albuminuria; Blood Urea Nitrogen; Cell Nucleus; Creatine; Humans; Hypertrophy; Kidney Tubules; Lupus | 1967 |
Diuretic properties of furosemide in renal disease.
Topics: Acid-Base Equilibrium; Adolescent; Adult; Aged; Amyloidosis; Blood Urea Nitrogen; Creatine; Diabetic | 1968 |
[Creatine metabolism disorders in dermatomyositis, progressive scleroderma, visceral and cutaneous lupus erythematosus and panarteritis bodosa].
Topics: Adolescent; Adult; Amyloidosis; Collagen Diseases; Creatine; Creatinine; Dermatomyositis; Female; Hu | 1968 |
[Transition and complications of SLE and related diseases].
Topics: Adrenal Cortex Hormones; Adult; Creatine; Creatinine; Dermatomyositis; Female; Humans; Lupus Erythem | 1968 |